Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Literature
1.
Kim HJ, Jung SM, Song JJ, Park YB, Lee SW (2018) Mean platelet volume can estimate the current vasculitis activity of microscopic polyangiitis. Rheumatol Int 38(6):1095–1101CrossRefPubMed
2.
Şahin A, Yetişgin A, Şahin M, Durmaz Y, Cengiz AK (2016) Can mean platelet volume be a surrogate marker of inflammation in rheumatic diseases? West Indian Med J 65(1):165–169
3.
4.
Tecer D, Sezgin M, Kanık A, İncel NA, Çimen ÖB, Biçer A, Şahin G (2016) Can mean platelet volume and red blood cell distribution width show disease activity in rheumatoid arthritis? Biomark Med 10(9):967–974CrossRefPubMed
5.
Gasparyan AY, Sandoo A, Stavropoulos-Kalinoglou A, Kitas GD (2010) Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-α therapy. Rheumatol Int 30(8):1125–1129CrossRefPubMed
6.
Lippi G, Massimo F (2015) Platelets and immunity: the interplay of mean platelet volume in health and disease. Expert Rev Hematol 8(5):555–557CrossRefPubMed
7.
Leader A, Pereg D, Lishner M (2012) Are platelet volume indices of clinical use? A multidisciplinary review. Ann Med 44(8):805–816CrossRefPubMed
8.
Lippi G, Pavesi F, Pipitone S (2015) Evaluation of mean platelet volume with four hematological analyzers: harmonization is still an unresolved issue. Blood Coagul Fibrinolysis 26:235–237CrossRefPubMed
Metadata
Title
The evaluation of mean platelet volume in microscopic polyangiitis: methodological drawbacks
Author
Ahmet Üşen
Publication date
01-09-2018
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 9/2018
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-018-4098-x

Other articles of this Issue 9/2018

Rheumatology International 9/2018 Go to the issue

Systematic Review

Lack of association between mean platelet volume and disease activity in systemic lupus erythematosus patients: a systematic review and meta-analysis

Patient Opinion

The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern

Epidemiology

Real-world incidence and prevalence of systemic lupus erythematosus in Alberta, Canada

Review

Rheumatology science and practice in India

Systematic Review

The effect of interactive digital interventions on physical activity in people with inflammatory arthritis: a systematic review

Public Health

Standardization of red flags for referral to rheumatologists and ophthalmologists in patients with rheumatic diseases and ocular involvement: a consensus statement
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits